Within tau-first APOE ε4 carriers, we found an increased rate of amyloid-β accumulation (via longitudinal amyloid PET), suggesting that this rare group may belong within the Alzheimer's disease continuum. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.